DANISH ATHLETE STUDY: OPEN CLINICAL TRIAL

 

The Effects of Essential Fatty Acids on Athletic Performance, General Well Being and Risk Factors for Cardiovascular Disease.

 

INDEX TO 7 MAJOR PARTS OF DANISH ATHLETE STUDY:

 

The Danish Athlete Study is comprised of seven main sections, two of which are reference charts containing graphs and tables. Please note - this is the Complete Study!

 

Each section is outlined and linked below:

PART 1: INTRODUCTION TO THE DANISH ATHLETE STUDY

Background information on the "who, how & where" of the study. Introduction to the project coordinator, Oscar Umahro Cadogan. Breakdown of the types of athletes that volunteered for the study.

PART 2: GENERAL EFFECTS & SIDE-EFFECTS; GRAPHICAL DATA

Breakdown of participants' dosing procedures; discussion of results in terms of athletic performance, improvement in inflammatory conditions, increases in lean mass, improvements in general well-being, improvement in mood & concentration and discussion of general side-effects. There is also a link-table to graphical data on all sets of side-effects.

PART 3: AN EXPLANATION OF THE MEASURED CARDIOVASULAR RISK FACTORS

This is a very informative overview of all the blood factors measured and chronicled as part of the study. For those without a physiology major, this is recommended reading! Covers measurements such as Fasting Glucose, Hemoglobin, Fibrinogen, Triglycerides, HDL & LDL cholesterol etc.

PART 4: HIGH DOSING WITH UDO'S OIL BLEND CHANGES CARDIOVASCULAR RISK FACTORS

In-depth measurements and discussion of the Cardiovascular Risk Factors discussed in Part 3. Tabular results of all blood constituents measured. Links to graphical data on CV RISK FACTORS.

PART 5: GRAPHICAL DATA ON CARDIOVASCULAR RISK FACTORS

These are reference graphs supporting the discussion in Part 4.

PART 6: SIXTY-ONE INDIVIDUAL CASE STUDIES:

PART 6A . . .  PART 6B . . .  PART 6C . . . 

Part 6 is divided into three parts that comprise the 61 individual case studies. Participants are categorized according to gender, age, smoker/ non-smoker, sport, and/or activity, and observations are made regarding significant side effects in special cases such as the Type 2 Diabetics that joined the study. Tabular data is offered including baseline and post-supplementation measurements of blood constituents.

PART 7: SIDE-EFFECTS: GRAPHICAL DATA

These are reference graphs supporting the discussion of Side Effects in Part 2 above.

Next   Index   Part 1   Part 2   Part 3   Part 4   Part 5   Part 6A   Part 6B   Part 6C   Part 7